These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Pharmacotherapy for Alzheimer's disease].
    Author: Verhey FR.
    Journal: Tijdschr Psychiatr; 2006; 48(1):17-26. PubMed ID: 16955982.
    Abstract:
    BACKGROUND: So far no causal therapies are available for the treatment of Alzheimer's disease. However, four drugs, namely donepezil, rivastigmine, galantamine and memantine, have been licensed for treating the symptoms of the disease. AIM: To systematically review the efficacy and side-effects of these drugs. METHOD: With the help of Pubmed, Medline and the Cochrane Library the literature was searched systematically. RESULTS: Cholinesterase-inhibitors and memantine do have a beneficial effect on cognition and daily functioning. The effect, however, is limited and the cholinesterase-inhibitors in particular frequently have side-effects. CONCLUSION: Treatment with the new anti-Alzheimer drugs demands a careful and realistic approach. The drugs should not be prescribed in isolation but the treatment needs to be embedded in the entire set of currently available psychosocial intervention techniques.
    [Abstract] [Full Text] [Related] [New Search]